유바이오틱스 시장 : 제품 유형별, 제형별, 기능별, 용도별, 최종 사용자별, 판매 채널별 시장 예측(2026-2032년)

The Eubiotics Market is projected to grow by USD 9.93 billion at a CAGR of 8.01% by 2032.

Eubiotics Market Executive Summary

The eubiotics market is moving from a niche feed-additive category to a core animal health, gut health, and sustainable livestock productivity strategy. Eubiotics, including probiotics, prebiotics, organic acids, essential oil compounds, enzymes, and synbiotics, support balanced intestinal microbiota, feed efficiency, immune resilience, and performance in poultry, swine, ruminants, aquaculture, and companion animals.

Demand is structurally supported by the global reduction of antibiotic growth promoters, stricter residue expectations across food supply chains, and consumer preference for responsibly raised meat, eggs, milk, and seafood. Regulatory precedents such as the European Union's 2006 ban on antibiotic growth promoters, the United States Veterinary Feed Directive implementation in 2017, and China's 2020 ban on growth-promoting antibiotics in feed have accelerated the commercial need for science-backed eubiotic alternatives.

Transformative Shifts in the Eubiotics Landscape

The eubiotics landscape is being reshaped by antimicrobial resistance policy, animal welfare standards, and the economics of feed conversion. Producers are seeking additives that can maintain productivity while reducing reliance on medically important antibiotics. This is elevating demand for validated probiotic strains, precision organic acid blends, yeast derivatives, phytogenic compounds, and combinations tailored to species, life stage, and production system.

Another major shift is the move from commodity additives to outcome-based gut health programs. Feed manufacturers and integrators increasingly evaluate eubiotics by measurable results such as improved average daily gain, reduced mortality, improved litter quality, lower pathogen pressure, and more consistent performance under heat stress or disease challenge. This favors suppliers with research depth, formulation expertise, strain traceability, and robust field-trial evidence.

Cumulative Impact of Artificial Intelligence on Eubiotics

Artificial intelligence is strengthening the eubiotics value chain by accelerating formulation design, microbiome interpretation, and performance prediction. Machine learning models can analyze feed composition, pathogen risk, farm environment, animal genetics, and historical performance data to identify additive combinations that are more likely to improve gut integrity and productivity.

AI also supports faster strain screening, fermentation optimization, quality control, and supply planning. In commercial production, computer vision, sensors, and predictive analytics can link animal behavior, feed intake, and health indicators with eubiotic intervention outcomes. The result is a more evidence-led market in which suppliers can shift from broad claims to precision nutrition recommendations backed by farm-level data.

Key Regional Insights Across the Eubiotics Market

Asia-Pacific is a high-priority eubiotics region due to large poultry, swine, aquaculture, and dairy sectors, rising protein consumption, and policy action to reduce antibiotic use in feed. China's feed antibiotic restrictions, India's expanding organized dairy and poultry industries, Japan's mature quality-driven feed sector, South Korea's advanced livestock systems, and Australia's emphasis on traceable animal production are supporting demand for probiotic, organic acid, enzyme, and phytogenic feed solutions.

North America remains a leading innovation and commercialization hub, supported by integrated livestock production, established feed additive regulation, and strong demand for antibiotic-free and no-antibiotics-ever production claims. Europe continues to shape global best practices through strict antimicrobial stewardship, sustainability policy, and advanced animal nutrition research, reinforced by long-standing restrictions on antibiotic growth promoters. Latin America, led by Brazil and Mexico, benefits from export-oriented poultry, beef, and pork industries that require efficient and residue-conscious production. The Middle East is increasingly focused on food security, modern poultry and dairy systems, and heat-stress resilience, while Africa is seeing rising relevance for eubiotics as poultry expansion, dairy modernization, feed efficiency needs, and animal disease management become more central to protein supply strategies.

Key Group Insights for Eubiotics Adoption

ASEAN demand is anchored by poultry, aquaculture, and swine production, with eubiotics gaining relevance as producers manage disease pressure, tropical climate stress, feed efficiency, and export standards. The GCC is focused on food security, modern poultry and dairy systems, controlled-environment farming, and feed efficiency in arid conditions, creating demand for additives that support gut health and resilience under heat stress.

The European Union remains one of the most influential eubiotics groups because its antimicrobial stewardship rules, animal welfare expectations, and sustainability objectives have shaped global feed practices. BRICS markets combine large livestock populations, rising protein demand, aquaculture expansion, and developing domestic feed industries, making them central to broad-based adoption. G7 countries drive premiumization, research intensity, regulatory transparency, and traceable animal nutrition programs, while NATO economies overlap with major North American and European feed markets where supply security, biosecurity, and resilient protein systems are strategic priorities.

Key Country Insights in the Eubiotics Market

The United States leads in integrated poultry, swine, dairy, and companion animal nutrition, with strong demand for eubiotics in antibiotic stewardship programs and antibiotic-free production systems. Canada's regulated feed sector and export-oriented livestock production support evidence-based adoption, while Mexico's poultry and pork industries are increasing use of gut health additives to improve productivity and manage disease pressure. Brazil is a major growth engine because its global poultry, pork, and beef exports require efficient, residue-conscious, and compliant production systems.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand due to long-standing restrictions on antibiotic growth promoters, advanced feed formulation practices, and established livestock sectors, while Russia's domestic protein strategy supports localized additive demand. In Asia-Pacific, China is pivotal following its ban on growth-promoting antibiotics in feed, India is expanding through dairy, poultry, and aquaculture modernization, Japan and South Korea favor high-quality, traceable, and performance-validated solutions, and Australia emphasizes productivity, biosecurity, animal welfare, and export-market credibility.

Actionable Recommendations for Eubiotics Industry Leaders

Industry leaders should prioritize clinically and commercially validated eubiotic portfolios that combine probiotics, prebiotics, organic acids, enzymes, and phytogenics for species-specific outcomes. Investment in strain documentation, stability data, mode-of-action research, palatability assessment, and field trials is essential for differentiation in a market increasingly governed by proof of performance.

Companies should also build digital nutrition platforms that connect feed formulation, animal health data, microbiome insights, and farm analytics. Partnerships with integrators, veterinarians, universities, and feed mills can shorten validation cycles and improve adoption. Regional strategies should align with local regulation, ingredient availability, disease challenges, climate conditions, protein-sector maturity, and producer economics.

Research Methodology for Eubiotics Market Analysis

The research methodology combines secondary research, regulatory review, and market triangulation across the animal nutrition and feed additive value chain. Sources include government animal health agencies, feed regulation frameworks, international organizations, peer-reviewed scientific literature, trade data, livestock production statistics, patent activity, product registration trends, and industry association publications.

Insights are validated through cross-comparison of regional policies, livestock production trends, feed additive adoption patterns, and product innovation signals. The analysis emphasizes verifiable drivers such as antibiotic reduction policies, species-specific production systems, documented shifts toward gut health, performance nutrition, antimicrobial stewardship, and sustainable animal agriculture.

Conclusion: The Future of Eubiotics

Eubiotics are becoming indispensable to modern animal nutrition as the livestock and aquaculture industries balance productivity, antimicrobial stewardship, welfare, and sustainability. The market's development is supported by regulatory momentum, consumer expectations, and producer demand for measurable gut health outcomes.

Future competitiveness will depend on scientific validation, digital integration, supply reliability, and regional customization. Organizations that pair proven biological solutions with data-driven advisory models will be best positioned to capture long-term value in the global eubiotics market while supporting healthier animals and more resilient food systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Eubiotics Market, by Product Type

• 7.1. Enzymes & Synbiotics
• 7.2. Organic Acids
• 7.3. Phytogenics
• 7.4. Prebiotics
• 7.5. Probiotics
  • 7.5.1. Bacillus
  • 7.5.2. Enterococcus
  • 7.5.3. Lactobacillus
  • 7.5.4. Saccharomyces

8. Eubiotics Market, by Form

• 8.1. Dry
• 8.2. Liquid

9. Eubiotics Market, by Function

• 9.1. Gut Health Improvement
• 9.2. Nutrient Absorption Enhancement
• 9.3. Immunity Boosting
• 9.4. Performance Optimization

10. Eubiotics Market, by Application

• 10.1. Poultry
• 10.2. Swine
• 10.3. Aquaculture
• 10.4. Ruminants

11. Eubiotics Market, by End User

• 11.1. Feed Manufacturers
• 11.2. Integrated Producers
• 11.3. On-Farm Mixers

12. Eubiotics Market, by Sales Channel

• 12.1. Offline
• 12.2. Online

13. Eubiotics Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Eubiotics Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Eubiotics Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Alltech Inc.
• 17.2. Archer Daniels Midland Company
• 17.3. BASF SE
• 17.4. BENEO GmbH
• 17.5. Bluestar Adisseo Company
• 17.6. Cargill, Incorporated
• 17.7. DSM-Firmenich AG
• 17.8. FrieslandCampina Ingredients
• 17.9. Huvepharma Inc.
• 17.10. International Flavors & Fragrances Inc.
• 17.11. Kemin Industries, Inc.
• 17.12. Lallemand Inc.
• 17.13. Land O'Lakes, Inc.
• 17.14. Lesaffre International
• 17.15. Novonesis A/S
• 17.16. Novus International, Inc.
• 17.17. Nutreco N.V.
• 17.18. Orffa Group
• 17.19. Phibro Animal Health Corporation
• 17.20. Vetagro S.p.A.